Treatment of underlying vasculitis leads to incomplete resolution of fatigue [9, 17]. Some studies show more severe fatigue in patients with MPO versus proteinase-3 (PR3) and microscopic polyangiitis (MPA) versus granulomatosis with polyangiitis (GPA) clinical patterns, though this is not universal [16]. This evidence concerns the gene MPO and vasculitis.